Today: 16 May 2026
Browse Category

WSE:MOLE 24 March 2026

Molecure Starts Share Sale, KRUK Buys €278 Million Italian Debt as Korab Flags 2020 Mining Objection

Molecure Starts Share Sale, KRUK Buys €278 Million Italian Debt as Korab Flags 2020 Mining Objection

Molecure launched an accelerated bookbuild to sell up to 4.12 million new Series K shares and 2 million existing shares, with MS Galleon maintaining its 24.46% stake. KRUK’s Milan unit agreed to buy up to €278 million in Italian unsecured retail receivables. Korab Resources highlighted an ongoing mining-licence objection in Western Australia dating to December 2020.
24 March 2026
····

Stock Market Today

  • Canada’s Infrastructure Boom Boosts TSX Stocks Calian Group, Bird Construction, WSP Global
    May 15, 2026, 8:47 PM EDT. Canada's infrastructure investment surge is poised to benefit key TSX stocks. Calian Group (TSX:CGY) gained 49% in 2026 with an 18% revenue rise and a $1.5 billion backlog, driven by defence contracts. Bird Construction (TSX:BDT), up 78% this year, holds a $5.4 billion backlog, specializing in industrial projects with improving profit margins. WSP Global (TSX:WSP), a $25 billion capped engineering firm, also stands to profit. These stocks reflect Canada's focus on economic growth through enhanced infrastructure and deregulation supporting national projects.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop